Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating acute nonlymphocytic leukemia.

K E Richert-Boe, G C Bagby

    Geriatrics
    |February 1, 1978
    PubMed
    Summary

    Treatment for acute nonlymphocytic leukemia has improved for older adults. Combination chemotherapy can achieve complete remissions in 20-50% of patients over 50, making aggressive therapy vital for all ages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expression.

    British journal of cancer·2008
    Same author

    The Fanconi anemia group C gene product: signaling functions in hematopoietic cells.

    Experimental hematology·2001
    Same author

    The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.

    Blood·2001
    Same author

    FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity.

    The EMBO journal·2001
    Same author

    Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes.

    Blood·2001
    Same author

    Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.

    Blood·2001

    Area of Science:

    • Oncology
    • Hematology

    Background:

    • Acute leukemia is a significant concern in middle-aged and elderly populations.
    • Recent advancements have improved treatment options for acute nonlymphocytic leukemia.

    Purpose of the Study:

    • To evaluate the efficacy of current treatment strategies for acute nonlymphocytic leukemia in older adults.
    • To emphasize the importance of aggressive therapy for all patients with acute leukemia, irrespective of age.

    Main Methods:

    • Review of recent treatment programs for acute nonlymphocytic leukemia.
    • Analysis of combination chemotherapy effectiveness in patients over 50.
    • Assessment of supportive care advancements during marrow hypoplasia.

    Main Results:

    • Combination chemotherapy shows effectiveness in a significant number of older patients.
    • Complete remission rates in patients over 50 range from 20% to 50%.
    • Supportive therapy during marrow hypoplasia has notably improved.

    Conclusions:

    • Aggressive treatment for acute leukemia is beneficial for older patients.
    • Age should not be a barrier to receiving effective acute leukemia therapy.
    • Improved supportive care enhances treatment outcomes in elderly leukemia patients.

    Related Experiment Videos